 Vancouver, British Columbia and Minneapolis, Minnesota--Newsfile Corp. - May 13, 2021 - Neovasc Inc. Neovasc or the Company NASDAQ: NVCN TSX: NVCN today announced that it will sponsor a symposium presenting the latest long-term clinical data on the ReducerTM Reducer, highlighting its easy integration into current cardiovascular and microvascular disease treatments. The symposium titled, Latest clinical evidence and practical aspects to start Reducer therapy in your center, will be presented at the 2021 EuroPCR, taking place... 